Screener
Crinetics Pharmaceuticals CRNX Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by Crinetics Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The source filing: Crinetics Pharmaceuticals’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:21 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001658247-26-000040
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Operating lease right-of-use assets | 39,790 | 40,492 |
| Restricted cash, net of current portion | 800 | 800 |
| Prepaid expenses and other assets, net of current portion | 24,822 | 22,327 |
| TOTAL ASSETS | $1,401,323 | $1,126,257 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| CURRENT LIABILITIES | ||
| Accounts payable and accrued expenses | $37,487 | $41,770 |
| Accrued compensation and related expenses | 25,792 | 35,578 |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Crinetics Pharmaceuticals's total assets?
- Crinetics Pharmaceuticals (CRNX) reported total assets of $1.4B in Q1 2026.
- How has Crinetics Pharmaceuticals's total assets changed year-over-year?
- Crinetics Pharmaceuticals's total assets increased by 2.9% year-over-year, from $1.36B to $1.4B.
- What is the long-term trend for Crinetics Pharmaceuticals's total assets?
- Over 5 years (2020 to 2025), Crinetics Pharmaceuticals's total assets has grown at a 43.8% compound annual growth rate (CAGR), from $183.45M to $1.13B.
- What does total assets mean?
- The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.
Ask your AI about Crinetics Pharmaceuticals's total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude